SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is currently a focal point for the community due to the upcoming FDA advisory committee meetings regarding the regulation of various peptides, which could significantly impact the company's growth strategy. Investors are closely monitoring the potential for a regulatory catalyst while simultaneously debating the impact of aggressive short interest and recent analyst activity on the stock's near-term volatility.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors react to the announcement of a new device-leasing program in partnership with Klarna, designed to drive upgrade cycles across its hardware ecosystem. Community sentiment remains polarized, with bulls highlighting the stock as a resilient market leader with strong free cash flow, while bears question the company's innovation and suspicious price action without major fundamental catalysts.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant market volatility after a strong earnings report and raised guidance triggered an initial rally that subsequently reversed. The community is actively debating whether the company's turnaround is sustainable given lingering questions about foundry execution, capital expenditure requirements, and broader semiconductor sector weakness.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is currently trending due to high retail engagement and aggressive institutional accumulation surrounding the company's anticipated anchor tenant announcement and its massive Project Matador data center infrastructure. The community is actively debating the company's valuation, the potential for a short squeeze, and the impact of the recent conclusion of a high-profile proxy fight on future operations.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as China adds the company to its export control list, sparking debate among investors regarding the long-term impact on its domestic supply chain versus potential supply bottlenecks. The community remains divided, with many viewing the stock's recent volatility as a strategic 'buy the dip' opportunity due to the company's critical role in U.S. national security and defense, while others express frustration over persistent short-selling pressure.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is rallying as escalating geopolitical instability in the Strait of Hormuz tightens global LNG supplies, driving up spot market prices and expanding profit margins for the company's export operations. The community is actively discussing a surge in liquefaction fees and strong production growth, with many investors viewing the stock as a strategically undervalued energy play despite the ongoing volatility and market-maker suppression.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the community debates the implications of a negative CHMP opinion for its arimoclomol treatment, with many investors closely watching the company's planned re-examination process. While some express frustration over regulatory setbacks and leadership, a significant portion of the community remains focused on the company's U.S. revenue growth, strong cash position, and the potential for a reversal of the European decision.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing intense downward pressure as investors increasingly question its high valuation and the lack of realized revenue from long-term AI and robotics projects. While some in the community are aggressively shorting the stock in anticipation of further slides toward psychological support levels, others see the recent volatility as a buying opportunity, leading to heated debates over whether the company's future potential justifies its current price.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is trending as investors weigh strong brand momentum, highlighted by robust HOKA growth and recent earnings beats, against ongoing concerns about growth rate moderation and sector-wide tariff pressures. The community remains divided, with many retail investors calling the post-earnings pullback an overreaction given the company's strong cash position and active share buyback programs, while others remain cautious about valuation and analyst sentiment.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending due to heightened geopolitical tensions in the Middle East, specifically reports of a naval blockade and ongoing military strikes that threaten global energy supply chains. Market participants are actively debating the potential for long-term oil supply disruptions against speculative headlines surrounding diplomatic ceasefire efforts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier

Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier PR Newswire SAN DIEGO, July...

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules PR Newswire SAN DIEGO, July 6, 2026 SAN DIEGO, July 6, 2026 /PRNewswire...

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier PR Newswire SAN DIEGO, June 26...

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, June 10, 2026 Australian oncology study advances into Cohort 3 as enrollment...

The Next Meme Stock Wave?

A fresh wave of speculative activity swept through the small-cap market this week as traders piled into a combination of AI-linked companies, China-based growth stories, and emerging defense contractors. $BLIS, $GMM, $PAVS, $AEMD, $PAYO, $AZI, $CGTL, $CCSC, $ELPW, $JZXN, $MTEN

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 PR Newswire SAN DIEGO, June 2, 2026 SAN DIEGO, June 2, 2026 /PRNewswire/ --Aethlon Medical...

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness PR Newswire SAN DIEGO, May 21, 2026 SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ...

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities PR Newswire SAN DIEGO, March 12, 2026 SAN...

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 PR Newswire SAN DIEGO, Feb. 23...

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

Aethlon Medical Inc

Why Did Aethlon Medical Stock Tumble Over 12% Today?

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.79	--	--	N/A
Q4 '25	-$2.17	$4.08	288.40%	BEAT
Q3 '25	-$2.75	-$2.45	10.91%	BEAT
Q2 '25	-$3.66	-$3.74	-2.09%	MISSED
Q1 '25	-$0.86	-$8.50	-887.30%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

AEMDAethlon Medical Inc

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AEMD News